Professor Sir Nicholas J White
Podcast interview
Improving the treatment of infectious diseases
With nearly 50 years in malaria research and more recent focus on COVID-19, research at MORU led to more effective treatments. In COVID-19, trials debunked drugs like ivermectin or favipiravir, but validated remdesivir, molnupiravir and protease inhibitors. As malaria faces drug resistance, triple therapies offer hope. MORU research aims for tangible health impacts, with an approach applicable to other infectious diseases.
Colleges
Nicholas White
FRS
Professor of Tropical Medicine
- Professor at Mahidol University in Thailand
Professor White’s diverse interests include the epidemiology, pathophysiology and management of uncomplicated and severe malaria, meliodosis, enteric fever, tetanus, dengue haemorrhagic fever, Japanese encephalitis and tuberculosis. His particular interests at present include the pathophysiology and treatment of severe malaria, the prevention of antimalarial drug resistance using artemisinin-based combinations. and the biology of relapse in vivax malaria.
Professor Sir Nick White passed away on the 1st February 2026
Recent publications
Accurate Measurement of Viral Clearance in Early-Phase Antiviral Studies in Coronavirus Disease 2019.
Journal article
Wongnak P. et al, (2026), J Infect Dis, 233, e582 - e584
Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood.
Journal article
Saito M. et al, (2026), Clin Infect Dis, 82, e165 - e173
Population pharmacokinetics of artemether-lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria.
Journal article
Ding J. et al, (2026), Br J Clin Pharmacol, 92, 589 - 605
Cerebral malaria: of mice and men.
Journal article
Weerasekera CJ. and White NJ., (2025), Trans R Soc Trop Med Hyg
Pharmacometric evaluation of sulfadoxine-pyrimethamine- amodiaquine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda.
Journal article
Bonnington C. et al, (2025), Clin Infect Dis
